4 research outputs found
Non-Gaussian modelling and statistical denoising of Planck dust polarisation full-sky maps using scattering transforms
Scattering transforms have been successfully used to describe dust polarisation for flat-sky images. This paper expands this framework to noisy observations on the sphere with the aim of obtaining denoised Stokes Q and U all-sky maps at 353 GHz, as well as a non-Gaussian model of dust polarisation, from the Planck data. To achieve this goal, we extended the computation of scattering coefficients to the HEALPix pixelation and introduced cross-statistics that allowed us to make use of half-mission maps as well as the correlation between dust temperature and polarisation. Introducing a general framework, we developed an algorithm that uses the scattering statistics to separate dust polarisation from data noise. The separation was validated on mock data before it was applied to the SRoll2Planck maps at Nside = 256. The validation shows that the statistics of the dust emission, including its non-Gaussian properties, are recovered until âmax ~ 700, where, at high Galactic latitudes, the dust power is weaker than that of the dust by two orders of magnitude. On scales where the dust power is weaker than one-tenth of the power of the noise, structures in the output maps have comparable statistics, but are not spatially coincident with those of the input maps. Our results on Planck data are significant milestones opening new perspectives for statistical studies of dust polarisation and for the simulation of Galactic polarised foregrounds. The Planck denoised maps are available (see http://sroll20.ias.u-psud.fr/sroll40_353_data.html) together with results from our validation on mock data, which may be used to quantify uncertainties
Surgical treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
International audienceOBJECTIVE The Treatment of Brain Arteriovenous Malformations Study (TOBAS) is a pragmatic study that includes 2 randomized trials and registries of treated or conservatively managed patients. The authors report the results of the surgical registry. METHODS TOBAS patients are managed according to an algorithm that combines clinical judgment and randomized allocation. For patients considered for curative treatment, clinicians selected from surgery, endovascular therapy, or radiation therapy as the primary curative method, and whether observation was a reasonable alternative. When surgery was selected and observation was deemed unreasonable, the patient was not included in the randomized controlled trial but placed in the surgical registry. The primary outcome of the trial was mRS score > 2 at 10 years (at last follow-up for the current report). Secondary outcomes include angiographic results, perioperative serious adverse events, and permanent treatment-related complications leading to mRS score > 2. RESULTS From June 2014 to May 2021, 1010 patients were recruited at 30 TOBAS centers. Surgery was selected for 229/512 patients (44%) considered for curative treatment; 77 (34%) were included in the surgery versus observation randomized trial and 152 (66%) were placed in the surgical registry. Surgical registry patients had 124/152 (82%) ruptured and 28/152 (18%) unruptured arteriovenous malformations (AVMs), with the majority categorized as low-grade Spetzler-Martin grade IâII AVM (118/152 [78%]). Thirteen patients were excluded, leaving 139 patients for analysis. Embolization was performed prior to surgery in 78/139 (56%) patients. Surgical angiographic cure was obtained in 123/139 all-grade (89%, 95% CI 82%â93%) and 105/110 low-grade (95%, 95% CI 90%â98%) AVM patients. At the mean follow-up of 18.1 months, 16 patients (12%, 95% CI 7%â18%) had reached the primary safety outcome of mRS score > 2, including 11/16 who had a baseline mRS score â„ 3 due to previous AVM rupture. Serious adverse events occurred in 29 patients (21%, 95% CI 15%â28%). Permanent treatment-related complications leading to mRS score > 2 occurred in 6/139 patients (4%, 95% CI 2%â9%), 5 (83%) of whom had complications due to preoperative embolization. CONCLUSIONS The surgical treatment of brain AVMs in the TOBAS registry was curative in 88% of patients. The participation of more patients, surgeons, and centers in randomized trials is needed to definitively establish the role of surgery in the treatment of unruptured brain AVMs. Clinical trial registration no.: NCT02098252 ( ClinicalTrials.gov
Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations
The Treatment of Brain Arteriovenous Malformations Study (TOBAS) is an all-inclusive pragmatic study comprising 2 randomized clinical trials (RCTs). Patients excluded from the RCTs are followed in parallel treatment and observation registries, allowing a comparison between RCT and registry patients
Successful Thrombectomy Improves Functional Outcome in Tandem Occlusions with a Large Ischemic Core
International audienceBackground: Emergent stenting in tandem occlusions and mechanical thrombectomy (MT) of acute ischemic stroke related to large vessel occlusion (LVO-AIS) with a large core are tested independently. We aim to assess the impact of reperfusion with MT in patients with LVO-AIS with a large core and a tandem occlusion and to compare the safety of reperfusion between large core with tandem and nontandem occlusions in current practice. Methods: We analyzed data of all consecutive patients included in the prospective Endovascular Treatment in Ischemic Stroke Registry in France between January 2015 and March 2023 who presented with a pretreatment ASPECTS (Alberta Stroke Program Early CT Score) of 0â5 and angiographically proven tandem occlusion. The primary end point was a favorable outcome defined by a modified Rankin Scale (mRS) score of 0â3 at 90 days. Results: Among 262 included patients with a tandem occlusion and ASPECTS 0â5, 203 patients (77.5%) had a successful reperfusion (modified Thrombolysis in Cerebral Infarction grade 2b-3). Reperfused patients had a favorable shift in the overall mRS score distribution (adjusted odds ratio [aOR], 1.57 [1.22â2.03]; P < 0.001), higher rates of mRS score 0â3 (aOR, 7.03 [2.60â19.01]; P < 0.001) and mRS score 0â2 at 90 days (aOR, 3.85 [1.39â10.68]; P = 0.009) compared with nonreperfused. There was a trend between the occurrence of successful reperfusion and a decreased rate of symptomatic intracranial hemorrhage (aOR, 0.5 [0.22â1.13]; P = 0.096). Similar safety outcomes were observed after large core reperfusion in tandem and nontandem occlusions. Conclusions: Successful reperfusion was associated with a higher rate of favorable outcome in large core LVO-AIS with a tandem occlusion, with a safety profile similar to nontandem occlusion